CSBR:NASDAQ
Champions Oncology Inc
US$ ४.७०
arrow_upward
+१.१८%(+०.०५५) 1D
नोभेम्बर १३, १६:००:०० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$ ४.५७
High
US$ ४.७०
Low
US$ ४.५२
Mkt. cap
६.५५ करोड
Avg. vol.
८.१६ हजार
Volume
३.०२ हजार
52-wk high
US$ ८.३१
52-wk low
US$ ४.५२
EPS
-US$ ०.०८
Beta
०.४७
Shares outstanding
१.३९ करोड
No. of employees
२१७
Open
US$ ४.५७
High
US$ ४.७०
Low
US$ ४.५२
Mkt. cap
६.५५ करोड
Avg. vol.
८.१६ हजार
Volume
३.०२ हजार
52-wk high
US$ ८.३१
52-wk low
US$ ४.५२
EPS
-US$ ०.०८
Beta
०.४७
Shares outstanding
१.३९ करोड
No. of employees
२१७
News stories
From web sources and news partners
FourWeekMBA
·
१८ मिनेट पहिले
Nvidia’s CEO-Exit Drop Took $384 Off a $100K S&P 500 Fund
BigGo Finance
·
२५ मिनेट पहिले
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
२ घण्टा पहिले
History Says Every S&P 500 Bear Market Has Ended the Same Way. Here's the Pattern.
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees२१७
Founded२००७
HeadquartersHackensack, न्यु जर्सी, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitechampionsoncology.com